BioLeaders

Nazneen Rahman BioLeader Interview - Dr Nazneen Rahman, Founder & CEO YewMaker, NED AstraZeneca (June 2021) Nazneen Rahman CBE, MD, PhD, FRCP, FMedSci Nazneen Rahman has made significant contributions to science and medical research over the last 25 years. She is an internationally recognised expert in cancer genomics and was Professor of Human Genetics at the Institute of Cancer Research and Head of Cancer Genetics at the Royal Marsden Hospital, London until 2018. Nazneen is a Non-Executive Director at AstraZeneca, Chair of the AstraZeneca Science Committee and oversees Sustainability for the Board. Nazneen is now focussed on making healthcare [...]

Peter Joyce BioLeader Interview - Peter Joyce (April 2021) Peter Joyce is Co-founder and Chief Executive Officer of Grey Wolf, having founded the Company in 2017 with Tom McCarthy. Prior to Grey Wolf Peter was at Vertex Pharmaceuticals where he led drug discovery projects, had responsibility for leading a number of target identification teams that led to multiple novel drug discovery projects and was involved in delivering clinical drug candidates. Peter has a broad scientific experience across therapeutic areas having worked on projects in oncology, genetic diseases and neurodegeneration. He also pioneered the development of complex neurological assays suitable [...]

Eric Mayes BioLeader Interview - Eric Mayes (April 2021) Dr Eric Mayes is CEO of Endomag and has over 20 years’ experience in developing and leading materials technology companies spanning data storage, display technology, printed electronics and medical devices. Eric has led oncology-focused Endomag through its rapid growth since marketing its first device for staging breast cancer in late 2012. The company has now helped over 130,000 patients receive a higher standard of care in over 550 hospitals across 43 countries. Prior to joining Endomag in 2010, Eric served as Director of Commercial Development for Cambridge Display Technology (CDT) [...]

Huw Jones BioLeader Interview - Huw Jones (March 2021) For over 20 years, Huw Jones has been a serial CEO and NED of early stage and listed biotech companies. Throughout his varied career he has launched dozens of new medicines, in several countries, completed tens of M&A transactions and managed many drug development programmes. He was appointed CEO of Evgen Pharma PLC, in October 2020, an AIM listed, clinical stage cancer and inflammation company. He recently led the raise of £10m in a placing and up to a further £1m in an open offer in a heavily oversubscribed and [...]

Thomas Weaver BioLeader Interview - Thomas Weaver (March 2021) I am a native Wisconsinite who trained at the University in Madison (BSc in Math and Biochem, PhD in Oncology) but then moved to the UK 30 years ago as a postdoc at the MRC Laboratory of Molecular Biology in Cambridge. This was an exciting time in Cambridge with many labs just starting to apply large scale genetic and molecular screens to characterize biological processes from embryology to normal adult physiology and disease. The Human Genome Project was a natural extension of this endeavour and my involvement/interest was, and still [...]

Thomas Pedersen BioLeader Interview - Thomas Pedersen (December 2020) Thomas has an academic background in skeletal muscle physiology and neuromuscular disease. He holds a PhD in Physiology from Aarhus University and he did two years of post doctoral work at Cambridge University. Thomas has years of experience in cellular electrophysiology and he has published more than 30 high-ranking papers including a first author paper in Science and several papers in The Journal of General Physiology. NMD Pharma was founded on scientific discoveries obtained in the Muscle Laboratory at Aarhus University in which Thomas holds a position as Associate Professor. Key [...]

Ian Campbell BioLeader Interview - Ian Campbell (December 2020) Dr Ian Campbell is the recently appointed Chief Business Officer (CBO) with LifeArc and is responsible for business development and partnerships – a key component in accelerating the translation of life sciences innovation into benefits for patients. Ian was previously interim executive chair at Innovate UK, and before that Director for Health and Life Sciences. Prior to Innovate, Ian was Chief Executive of Arquer Diagnostics, a company developing and commercialising immunoassay tests for cancers of the urogenital tract. A graduate of the University of Glasgow, Ian holds a PhD in Biochemistry. [...]

Annalisa Jenkins BioLeader Interview - Annalisa Jenkins (November 2020) Annalisa Jenkins, M.B.B.S., F.R.C.P. is a biopharma thought leader with over 25 years of industry experience. Dr. Jenkins has extensive recent experience in building and financing biotech companies pursuing cures for the most challenging rare diseases to address important medical issues globally. She has consistently built and led teams advancing programs from scientific research through clinical development, regulatory approval, and into healthcare systems globally. In addition, she is an advocate for diversity and inclusion, particularly for women in science. Dr. Jenkins served as president and CEO of Dimension Therapeutics, a leading [...]

Alexis Peyroles BioLeader Interview - Alexis Peyroles (November 2020) I am currently the CEO of OSE Immunotherapeutics, a French clinical stage listed biotech focused on immunotherapy; with innovative products under development in both immune-oncology and auto-immune diseases. Married with two children we are based near Paris. I graduated from EDHEC Business School and completed an executive MBA with Imperial College, London. Key milestones in your career journey to date? My early career was spent in Japan; after which I joined SANOFI where I had different roles in Finance and Business Development covering Asia and Eastern Europe. In 2005 I joined [...]

Claus Oleson BioLeader Interview - Claus Oleson (October 2020) CEO and co-founder of STipe Therapeutics, a Biotech company developing a first in Class drug that harnesses the robust striking power of the innate immune system by sensitizing the STING pathway. Claus is 46 year's old living in Denmark and married to Mie Olesen and farther of 3 teenagers. Claus Elsborg Olesen earned his PhD in Physiology and Biophysics from Aarhus University in 2008 and has been engaged in both basic and applied research with an emphasis on structural biology and function of membrane proteins ever since. Dr. Olesen has identified [...]